Viewing nowAtroad 10 mg Tablets (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
White Life Science Co., Ltd.

MFDS item code 201309332 · Approved 2013.09.13 · Insurance code 625200130
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It decreases the risk of complications related to heart diseases such as myocardial infarction, stroke, vascular surgery, and angina in adult patients with multiple risk factors for major heart diseases or with type 2 diabetes. It also helps reduce the risk of non-fatal myocardial infarction, fatal and non-fatal strokes, the need for vascular surgery, heart failure hospitalization, and angina in patients who already have heart diseases. Furthermore, it is effective in lowering total cholesterol, LDL cholesterol, apo-B protein, and triglycerides levels, and increasing HDL cholesterol levels in patients with hyperlipidemia. This medication is also used to improve high cholesterol issues in children and adolescents with a family history or risk factors for heart disease. Overall, it is used to enhance cardiovascular health and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, regardless of food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL-cholesterol levels may start with 20 mg or 40 mg once daily (only when a reduction in LDL-cholesterol levels of 45 % or greater is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the treatment goal is to lower LDL-cholesterol, it is recommended that LDL-cholesterol levels be used when initiating treatment and evaluating response. However, if LDL-cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL-cholesterol-lowering effect; therefore, dose adjustment is not necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this drug in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.
This medication may carry a risk of muscle problems, so it should be discontinued immediately if severe muscle pain or weakness occurs, or if there is a significant increase in creatine kinase levels. In particular situations such as severe infections, hypotension, major surgery, or trauma, treatment may need to be paused. This medication should not be used by individuals with certain allergic reactions, severely impaired liver function, muscle disorders, pregnant or breastfeeding women, children under 10 years of age, or those taking certain antiviral agents. Patients with liver or kidney diseases, the elderly, or those with hypothyroidism - who are at a higher risk of muscle problems - should use this medication cautiously, and it is important to periodically check the muscle condition and blood tests before and during treatment. Generally, this medication has few side effects, but various symptoms such as fatigue, indigestion, headache, muscle pain, liver function abnormalities, and allergic reactions may occur, so consult a doctor if any unusual symptoms arise. Also, since this medication is metabolized in the liver, patients with liver diseases should undergo liver function tests before starting and regularly during treatment. Women who could become pregnant must use effective contraception while taking this medication, and if pregnancy is confirmed, use must be stopped immediately. This medication can interact with various drugs, so if other medications are being taken, it is essential to inform a doctor or pharmacist, especially when used in combination with certain antibiotics, antifungals, antivirals, immunosuppressants, grapefruit juice, etc. In case of overdose, there is no specific antidote, so treatment will be according to symptoms, monitoring liver function and muscle enzyme levels. This medication should be kept out of reach of children and stored in its original container, and ongoing collection of safety and side effects data from clinical trials and post-marketing surveys necessitates regular consultations with healthcare professionals.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the medication's effectiveness for a longer duration.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
White Life Science Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.